院外心脏骤停后院前与院内阶段的合并症负担与生存率
该研究基于荷兰2010—2014年前瞻性院外心脏骤停登记数据,纳入2510例年龄≥18岁的患者,采用Charlson合并症指数(CCI)评估累积合并症负担,用logistic回归分析CCI与总体生存(院外心脏骤停至出院)、院前生存(院外心脏骤停至入院)及院内生存(入院至出院)的关系。结果显示,CCI与总体生存率显著相关(OR 0.71;95%CI 0.61-0.83;P < 0.01),与院前生存率无显著关联(OR 0.96;95%CI 0.76-1.23;P = 0.92),而与院内生存率显著负相关(OR 0.41;95%CI 0.27-0.62;P = 0.01)。CCI对院前和院内生存的相对贡献分别为1.1%和8.1%。作者认为,既往高合并症负担在院外心脏骤停后生存率降低中作用有限,且仅体现在院内阶段,该数据可能有助于临床医生在与高合并症负担患者进行预立医疗照护计划时讨论复苏选择。
要点
- 在2510例院外心脏骤停患者中,CCI与总体生存率显著相关(OR 0.71;95%CI 0.61-0.83;P < 0.01)。
- CCI与院前生存率无显著关联(OR 0.96;95%CI 0.76-1.23;P = 0.92)。
- 高CCI与低院内生存率显著相关(OR 0.41;95%CI 0.27-0.62;P = 0.01)。
- CCI对院前和院内生存的相对贡献分别为1.1%和8.1%。
- 作者认为,该数据可能有助于临床医生在与高合并症负担患者进行预立医疗照护计划时讨论复苏选择。
适用人群与场景
- 荷兰2010—2014年前瞻性院外心脏骤停登记中年龄≥18岁的院外心脏骤停患者,共2510例。
研究设计与关键结果
- 研究类型为基于前瞻性院外心脏骤停登记数据的分析,纳入2510例年龄≥18岁的院外心脏骤停患者,评估Charlson合并症指数(CCI)与院前、院内及总体生存率的关联。
- CCI与总体生存率(院外心脏骤停至出院)显著相关:OR 0.71;95%CI 0.61-0.83;P < 0.01。
- CCI与院前生存率(院外心脏骤停至入院)无显著关联:OR 0.96;95%CI 0.76-1.23;P = 0.92。
- 高CCI与低院内生存率(入院至出院)显著相关:OR 0.41;95%CI 0.27-0.62;P = 0.01。
- CCI对院前生存和院内生存的相对贡献分别为1.1%和8.1%。
证据类型、等级与局限
- 证据类型:基于前瞻性院外心脏骤停登记数据的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,既往高合并症负担在院外心脏骤停后生存率降低中作用有限,且仅体现在院内阶段。
- 作者认为,本研究提供的数据可能有助于临床医生在与高合并症负担患者进行预立医疗照护计划时讨论复苏选择,可能有助于患者做出知情选择。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Cumulative disease burden may be associated with survival chances after out-of-hospital cardiac arrest (OHCA). The relative contributions of cumulative disease burden on survival rates at the pre-hospital and in-hospital phases of post-resuscitation care are unknown.
METHODS: The association between cumulative comorbidity burden as measured by the Charlson Comorbidity Index (CCI) and pre-hospital and in-hospital survival rates was studied using data (2010-2014) from a prospective OHCA registry in the Netherlands. The association between CCI and survival rate (overall survival [OHCA-hospital discharge], pre-hospital survival [OHCA-hospital admission] and in-hospital survival [hospital admission-hospital discharge]) was assessed using logistic regression analyses. The relative contributions of CCI on pre-hospital and in-hospital survival rates were determined using the Nagelkerke test.
RESULTS: We included 2510 OHCA patients aged ≥18y. CCI was significantly associated with overall survival rate (OR 0.71; 95%CI 0.61-0.83; P < 0.01). CCI was not associated with pre-hospital survival rate (OR 0.96; 95%CI 0.76-1.23; P = 0.92) whereas high CCI was significantly associated with low in-hospital survival rate (OR 0.41; 95%CI 0.27-0.62; P = 0.01). The relative contributions of CCI on pre-hospital and in-hospital survival were 1.1% and 8.1%, respectively.
CONCLUSION: Pre-existing high comorbidity burden plays a modest role in reducing survival rate after OHCA, and only in the in-hospital phase. The present study offers data that may guide clinicians in discussing resuscitation options during advance care planning with patients with high comorbidity burden. This may be helpful in creating a patients' informed choice.
参考来源
- Oving I, van Dongen LHPI, Deurholt SC, et al. Comorbidity and survival in the pre-hospital and in-hospital phase after out-of-hospital cardiac arrest. Resuscitation. 2020. PMID: 32502577. doi:10.1016/j.resuscitation.2020.05.035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。